{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:10:11Z","timestamp":1792055411047,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,2,8]],"date-time":"2012-02-08T00:00:00Z","timestamp":1328659200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1038\/ejhg.2012.12","type":"journal-article","created":{"date-parts":[[2012,2,8]],"date-time":"2012-02-08T17:13:38Z","timestamp":1328721218000},"page":"870-877","source":"Crossref","is-referenced-by-count":20,"title":["C4ST-1\/CHST11-controlled chondroitin sulfation interferes with oncogenic HRAS signaling in Costello syndrome"],"prefix":"10.1038","volume":"20","author":[{"given":"Michael","family":"Kl\u00fcppel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payman","family":"Samavarchi-Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kela","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L","family":"Wrana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Hinek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,8]]},"reference":[{"key":"BFejhg201212_CR1","first-page":"114","volume":"13","author":"JM Costello","year":"1977","unstructured":"Costello JM : A new syndrome: mental subnormality and nasal papillomata. Aust Paediatr J 1977; 13: 114\u2013118.","journal-title":"Aust Paediatr J"},{"key":"BFejhg201212_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/ajmg.1320620203","volume":"62","author":"JM Costello","year":"1996","unstructured":"Costello JM : Costello syndrome: update on the original cases and commentary. Am J Med Genet 1996; 62: 199\u2013201.","journal-title":"Am J Med Genet"},{"key":"BFejhg201212_CR3","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00431-007-0558-0","volume":"167","author":"MC Digilio","year":"2008","unstructured":"Digilio MC, Sarkozy A, Capolino R et al: Costello syndrome: clinical diagnosis in the first year of life. Eur J Pediatr 2008; 167: 621\u2013628.","journal-title":"Eur J Pediatr"},{"key":"BFejhg201212_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/ajmg.c.10019","volume":"117C","author":"RC Hennekam","year":"2003","unstructured":"Hennekam RC : Costello syndrome: an overview. Am J Med Genet C Semin Med Genet 2003; 117C: 42\u201348.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"BFejhg201212_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0022-3476(98)70284-7","volume":"133","author":"JP Johnson","year":"1998","unstructured":"Johnson JP, Golabi M, Norton ME et al: Costello syndrome: phenotype, natural history, differential diagnosis, and possible cause. J Pediatr 1998; 133: 441\u2013448.","journal-title":"J Pediatr"},{"key":"BFejhg201212_CR6","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1136\/jmg.40.4.e37","volume":"40","author":"GM Mancini","year":"2003","unstructured":"Mancini GM, van Diggelen OP, Kleijer WJ et al: Studies on the pathogenesis of Costello syndrome. J Med Genet 2003; 40: e37.","journal-title":"J Med Genet"},{"key":"BFejhg201212_CR7","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/ajmg.a.32276","volume":"146A","author":"KA Rauen","year":"2008","unstructured":"Rauen KA, Hefner E, Carrillo K et al: Molecular aspects, clinical aspects and possible treatment modalities for Costello syndrome: Proceedings from the 1st International Costello Syndrome Research Symposium 2007. Am J Med Genet A 2008; 146A: 1205\u20131217.","journal-title":"Am J Med Genet A"},{"key":"BFejhg201212_CR8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/MOP.0b013e32834881dd","volume":"23","author":"M Zenker","year":"2011","unstructured":"Zenker M : Clinical manifestations of mutations in RAS and related intracellular signal transduction factors. Curr Opin Pediatr 2011; 23: 443\u2013451.","journal-title":"Curr Opin Pediatr"},{"key":"BFejhg201212_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/ajmg.c.30065","volume":"137C","author":"KW Gripp","year":"2005","unstructured":"Gripp KW : Tumor predisposition in Costello syndrome. Am J Med Genet C Semin Med Genet 2005; 137C: 72\u201377.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"BFejhg201212_CR10","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/ng1641","volume":"37","author":"Y Aoki","year":"2005","unstructured":"Aoki Y, Niihori T, Kawame H et al: Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat Genet 2005; 37: 1038\u20131040.","journal-title":"Nat Genet"},{"key":"BFejhg201212_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ajmg.a.31078","volume":"140","author":"AL Estep","year":"2006","unstructured":"Estep AL, Tidyman WE, Teitell MA, Cotter PD, Rauen KA : HRAS mutations in Costello syndrome: detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy. Am J Med Genet A 2006; 140: 8\u201316.","journal-title":"Am J Med Genet A"},{"key":"BFejhg201212_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajmg.a.31047","volume":"140","author":"KW Gripp","year":"2006","unstructured":"Gripp KW, Lin AE, Stabley DL et al: HRAS mutation analysis in Costello syndrome: genotype and phenotype correlation. Am J Med Genet A 2006; 140: 1\u20137.","journal-title":"Am J Med Genet A"},{"key":"BFejhg201212_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1136\/jmg.2005.040352","volume":"43","author":"B Kerr","year":"2006","unstructured":"Kerr B, Delrue MA, Sigaudy S et al: Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases. J Med Genet 2006; 43: 401\u2013405.","journal-title":"J Med Genet"},{"key":"BFejhg201212_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00109-006-0135-4","volume":"85","author":"CP Kratz","year":"2007","unstructured":"Kratz CP, Niemeyer CM, Zenker M : An unexpected new role of mutant Ras: perturbation of human embryonic development. J Mol Med (Berl) 2007; 85: 227\u2013235.","journal-title":"J Mol Med (Berl)"},{"key":"BFejhg201212_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1399-0004.2007.00743.x","volume":"71","author":"KA Rauen","year":"2007","unstructured":"Rauen KA : HRAS and the Costello syndrome. Clin Genet 2007; 71: 101\u2013108.","journal-title":"Clin Genet"},{"key":"BFejhg201212_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ajmg.a.32639","volume":"149A","author":"K Sol-Church","year":"2009","unstructured":"Sol-Church K, Stabley DL, Demmer LA et al: Male-to-male transmission of Costello syndrome: G12S HRAS germline mutation inherited from a father with somatic mosaicism. Am J Med Genet A 2009; 149A: 315\u2013321.","journal-title":"Am J Med Genet A"},{"key":"BFejhg201212_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/humu.20431","volume":"28","author":"G Zampino","year":"2007","unstructured":"Zampino G, Pantaleoni F, Carta C et al: Diversity, parental germline origin, and phenotypic spectrum of de novo HRAS missense changes in Costello syndrome. Hum Mutat 2007; 28: 265\u2013272.","journal-title":"Hum Mutat"},{"key":"BFejhg201212_CR18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/ajmg.c.30294","volume":"157","author":"KA Rauen","year":"2011","unstructured":"Rauen KA, Banerjee A, Bishop WR et al: Costello and cardio-facio-cutaneous syndromes: moving toward clinical trials in RASopathies. Am J Med Genet C Semin Med Genet 2011; 157: 136\u2013146.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"BFejhg201212_CR19","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1017\/S1462399408000902","volume":"10","author":"WE Tidyman","year":"2008","unstructured":"Tidyman WE, Rauen KA : Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway. Expert Rev Mol Med 2008; 10: e37.","journal-title":"Expert Rev Mol Med"},{"key":"BFejhg201212_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0304-4165(00)00016-7","volume":"1474","author":"O Habuchi","year":"2000","unstructured":"Habuchi O : Diversity and functions of glycosaminoglycan sulfotransferases. Biochim Biophys Acta 2000; 1474: 115\u2013127.","journal-title":"Biochim Biophys Acta"},{"key":"BFejhg201212_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S1877-1173(10)93006-8","volume":"93","author":"M Kl\u00fcppel","year":"2010","unstructured":"Kl\u00fcppel M : The roles of chondroitin-4-sulfotransferase-1 in development and disease. Prog Mol Biol Transl Sci 2010; 93: 113\u2013132.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"BFejhg201212_CR22","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.sbi.2003.08.002","volume":"13","author":"M Kusche-Gullberg","year":"2003","unstructured":"Kusche-Gullberg M, Kjellen L : Sulfotransferases in glycosaminoglycan biosynthesis. Curr Opin Struct Biol 2003; 13: 605\u2013611.","journal-title":"Curr Opin Struct Biol"},{"key":"BFejhg201212_CR23","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S0959-440X(00)00125-1","volume":"10","author":"K Sugahara","year":"2000","unstructured":"Sugahara K, Kitagawa H : Recent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans. Curr Opin Struct Biol 2000; 10: 518\u2013527.","journal-title":"Curr Opin Struct Biol"},{"key":"BFejhg201212_CR24","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1242\/dev.01948","volume":"132","author":"M Kl\u00fcppel","year":"2005","unstructured":"Kl\u00fcppel M, Wight TN, Chan C, Hinek A, Wrana JL : Maintenance of chondroitin sulfation balance by chondroitin-4-sulfotransferase 1 is required for chondrocyte development and growth factor signaling during cartilage morphogenesis. Development 2005; 132: 3989\u20134003.","journal-title":"Development"},{"key":"BFejhg201212_CR25","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1460-9568.2005.03876.x","volume":"21","author":"F Properzi","year":"2005","unstructured":"Properzi F, Carulli D, Asher RA et al: Chondroitin 6-sulphate synthesis is up-regulated in injured CNS, induced by injury-related cytokines and enhanced in axon-growth inhibitory glia. Eur J Neurosci 2005; 21: 378\u2013390.","journal-title":"Eur J Neurosci"},{"key":"BFejhg201212_CR26","first-page":"2324","volume":"59","author":"C Ricciardelli","year":"1999","unstructured":"Ricciardelli C, Quinn DI, Raymond WA et al: Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer. Cancer Res 1999; 59: 2324\u20132328.","journal-title":"Cancer Res"},{"key":"BFejhg201212_CR27","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/pros.20926","volume":"69","author":"C Ricciardelli","year":"2009","unstructured":"Ricciardelli C, Sakko AJ, Stahl J, Tilley WD, Marshall VR, Horsfall DJ : Prostatic chondroitin sulfate is increased in patients with metastatic disease but does not predict survival outcome. Prostate 2009; 69: 761\u2013769.","journal-title":"Prostate"},{"key":"BFejhg201212_CR28","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1158\/1055-9965.EPI-08-0204","volume":"17","author":"AJ Sakko","year":"2008","unstructured":"Sakko AJ, Butler MS, Byers S et al: Immunohistochemical level of unsulfated chondroitin disaccharides in the cancer stroma is an independent predictor of prostate cancer relapse. Cancer Epidemiol Biomarkers Prev 2008; 17: 2488\u20132497.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFejhg201212_CR29","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1158\/1078-0432.CCR-03-0146","volume":"10","author":"S Suwiwat","year":"2004","unstructured":"Suwiwat S, Ricciardelli C, Tammi R et al: Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer. Clin Cancer Res 2004; 10: 2491\u20132498.","journal-title":"Clin Cancer Res"},{"key":"BFejhg201212_CR30","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/modpathol.2008.70","volume":"21","author":"YH Teng","year":"2008","unstructured":"Teng YH, Tan PH, Chia SJ et al: Increased expression of non-sulfated chondroitin correlates with adverse clinicopathological parameters in prostate cancer. Mod Pathol 2008; 21: 893\u2013901.","journal-title":"Mod Pathol"},{"key":"BFejhg201212_CR31","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/(SICI)1096-9098(199808)68:4<250::AID-JSO9>3.0.CO;2-3","volume":"68","author":"P Vijayagopal","year":"1998","unstructured":"Vijayagopal P, Figueroa JE, Levine EA : Altered composition and increased endothelial cell proliferative activity of proteoglycans isolated from breast carcinoma. J Surg Oncol 1998; 68: 250\u2013254.","journal-title":"J Surg Oncol"},{"key":"BFejhg201212_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0925-4773(02)00198-3","volume":"118","author":"M Kl\u00fcppel","year":"2002","unstructured":"Kl\u00fcppel M, Vallis KA, Wrana JL : A high-throughput induction gene trap approach defines C4ST as a target of BMP signaling. Mech Dev 2002; 118: 77\u201389.","journal-title":"Mech Dev"},{"key":"BFejhg201212_CR33","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.biochi.2006.04.009","volume":"88","author":"CC Lopes","year":"2006","unstructured":"Lopes CC, Toma L, Pinhal MA et al: EJ-ras oncogene transfection of endothelial cells upregulates the expression of syndecan-4 and downregulates heparan sulfate sulfotransferases and epimerase. Biochimie 2006; 88: 1493\u20131504.","journal-title":"Biochimie"},{"key":"BFejhg201212_CR34","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1006\/bbrc.1994.1538","volume":"200","author":"M Romaris","year":"1994","unstructured":"Romaris M, Villena J, Molist A, Heredia A, Bassols A : Ras transformation alters the composition of extracellular matrix proteoglycans in rat fibroblasts. Biochem Biophys Res Commun 1994; 200: 925\u2013932.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFejhg201212_CR35","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1086\/302829","volume":"66","author":"A Hinek","year":"2000","unstructured":"Hinek A, Smith AC, Cutiongco EM, Callahan JW, Gripp KW, Weksberg R : Decreased elastin deposition and high proliferation of fibroblasts from Costello syndrome are related to functional deficiency in the 67-kD elastin-binding protein. Am J Hum Genet 2000; 66: 859\u2013872.","journal-title":"Am J Hum Genet"},{"key":"BFejhg201212_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajmg.a.30495","volume":"133A","author":"A Hinek","year":"2005","unstructured":"Hinek A, Teitell MA, Schoyer L et al: Myocardial storage of chondroitin sulfate-containing moieties in Costello syndrome patients with severe hypertrophic cardiomyopathy. Am J Med Genet A 2005; 133A: 1\u201312.","journal-title":"Am J Med Genet A"},{"key":"BFejhg201212_CR37","first-page":"185","volume":"71","author":"AA Jorge","year":"2009","unstructured":"Jorge AA, Malaquias AC, Arnhold IJ, Mendonca BB : Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS\/MAPK pathway. Horm Res 2009; 71: 185\u2013193.","journal-title":"Horm Res"},{"key":"BFejhg201212_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/humu.21377","volume":"32","author":"L Gremer","year":"2011","unstructured":"Gremer L, Merbitz-Zahradnik T, Dvorsky R et al: Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders. Hum Mutat 2011; 32: 33\u201343.","journal-title":"Hum Mutat"},{"key":"BFejhg201212_CR39","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/jhg.2011.85","volume":"56","author":"T Niihori","year":"2011","unstructured":"Niihori T, Aoki Y, Okamoto N et al: HRAS mutants identified in Costello syndrome patients can induce cellular senescence: possible implications for the pathogenesis of Costello syndrome. J Hum Genet 2011; 56: 707\u2013715.","journal-title":"J Hum Genet"},{"key":"BFejhg201212_CR40","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1159\/000051558","volume":"201","author":"A Hatamochi","year":"2000","unstructured":"Hatamochi A, Nagayama H, Kuroda K et al: Costello syndrome with decreased gene expression of elastin in cultured dermal fibroblasts. Dermatology 2000; 201: 366\u2013369.","journal-title":"Dermatology"},{"key":"BFejhg201212_CR41","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0002-9440(10)63103-3","volume":"164","author":"A Hinek","year":"2004","unstructured":"Hinek A, Braun KR, Liu K, Wang Y, Wight TN : Retrovirally mediated overexpression of versican v3 reverses impaired elastogenesis and heightened proliferation exhibited by fibroblasts from Costello syndrome and Hurler disease patients. Am J Pathol 2004; 164: 119\u2013131.","journal-title":"Am J Pathol"},{"key":"BFejhg201212_CR42","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/(SICI)1096-8628(19960202)61:4<304::AID-AJMG2>3.0.CO;2-U","volume":"61","author":"M Mori","year":"1996","unstructured":"Mori M, Yamagata T, Mori Y et al: Elastic fiber degeneration in Costello syndrome. Am J Med Genet 1996; 61: 304\u2013309.","journal-title":"Am J Med Genet"},{"key":"BFejhg201212_CR43","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.bbrc.2008.05.131","volume":"372","author":"Y Tatano","year":"2008","unstructured":"Tatano Y, Fujinawa R, Kozutsumi Y et al: Tropoelastin regulates chemokine expression in fibroblasts in Costello syndrome. Biochem Biophys Res Commun 2008; 372: 681\u2013687.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFejhg201212_CR44","first-page":"4682","volume":"49","author":"JL Bos","year":"1989","unstructured":"Bos JL : ras oncogenes in human cancer: a review. Cancer Res 1989; 49: 4682\u20134689.","journal-title":"Cancer Res"},{"issue":"Suppl 3","key":"BFejhg201212_CR45","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/j.joca.2008.06.006","volume":"16","author":"D Uebelhart","year":"2008","unstructured":"Uebelhart D : Clinical review of chondroitin sulfate in osteoarthritis. Osteoarthritis Cartilage 2008; 16 (Suppl 3): S19\u2013S21.","journal-title":"Osteoarthritis Cartilage"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg201212.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg201212","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg201212.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:05:35Z","timestamp":1684429535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg201212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,8]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["BFejhg201212"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2012.12","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,8]]}}}